Overview
Prima di candidarsi per questo ruolo, la preghiamo di leggere le seguenti informazioni su questa possibilità, riportate di seguito.
The Key Account Manager (KAM) is a field-based expert, that strategically drives the commercial objectives of Alnylam’s transthyretin amyloidosis (ATTR). The KAM will be primarily accountable for developing and implementing key account plans in their designated territory to optimize care for patients. Reporting to Area Sales Manager, the KAM is expected to develop territory specific strategic account plans in the context of the overall product strategy and in close alignment and collaboration with other functions such as Medical Affairs, while ensuring full compliance with all relevant company, industry, legal, regulatory and ethical standards.
Key Responsibilities
Presents a positive image of the company and develop/ reinforce awareness about RNAi platform to relevant customer groups.
Develop and Lead Regional/Hospital Market Access
Develops, own, and drives territory and account plan, including customer targeting, in line with country strategy in partnership with the Commercial and Medical Affairs team.
Achieves pre-launch and post-launch KPIs.
Performs detailed analysis of the assigned territory to identify, assess, and support the develop relevant centers for diagnosis and treatment.
Drives patient identification, diagnosis, and referral rates by executing against a territory strategy and account specific plans.
Develops trusted relationships with a portfolio of customers to ensure competitive advantage, after developing a thorough understanding of key customer needs and requirements.
Ensures the correct products and services are delivered to customers in a timely manner by collaborating with internal stakeholders (commercial, supply chain, and compliance) and external centers.
Establishes and maintains contact with key customers and provide commercial and scientific services to ensure access at site of care, and that logistics are in place to administer product.
Manages and executes local meetings to drive diagnosis and treatment rates, in collaboration with the Medical Affairs Team for physicians and other healthcare professionals.
Represents Alnylam at local and national events and congresses.
Serves as the link of communication between key customers and internal teams.
Liaises and collaborates with relevant internal staff (Medical Affairs, Commercial Leads, Marketing and Business Operations Manager), as required.
Timely and accurate reporting and continuous diligent maintenance of the CRM database.
Conducts all activities to highest ethical standards in accordance with country code of practice and local Laws and regulations.
Steers regular local alignment meetings with other field based functions to ensure proper implementation and outcomes against the committed territory and account plans.
Qualifications
University degree in a relevant scientific field, compliant with Italian regulatory requirements (D.Lgs. 219/2006). Equivalent qualifications as recognized by the Ministry of Health will also be considered.
5+ years of Sales and Key Account Management experience in bio/pharmaceutical sales
Ability to gain consistent access and develop strong & professional relationships for product promotion with healthcare providers in reference centers and the community
Effective communication and influencing skills to engage with professionals at all organizational levels
Strong business acumen to add value to the existing health care structures.
Ability to draw on previous experiences and insights to generate and maintain appropriate awareness and timely access to treatment
Excellent organizational and project management skills
Fluent in Italian and English, both written and verbal preferred
Ability to travel within a territory on a regular basis (80% of the time)
About Alnylam
Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture
Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. xlwpduy By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.
#J-18808-Ljbffr